MICRALAX

This brand name is authorized in Spain, United Kingdom

Active ingredients

The drug MICRALAX contains a combination of these active pharmaceutical ingredients (APIs):

1 Sodium citrate UNII 1Q73Q2JULR - SODIUM CITRATE, UNSPECIFIED FORM

Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section. Read about Sodium citrate

2 Sodium lauryl sulphoacetate UNII D0Y70F2B9J - SODIUM LAURYL SULFOACETATE

Read about Sodium lauryl sulphoacetate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A06AG11	Sodium lauryl sulfoacetate, incl. combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AG Enemas
Discover more medicines within A06AG11
A06AG20	Combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AG Enemas
Discover more medicines within A06AG20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 42509, 9155317-9155325, PL36301-0019
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 33522